oral glp-1 agonist Peptidyl and Non-Peptidyl Glucagon-Like Peptide-1 Receptor Agonists The Impact of GLP-1 Receptor
Description
These CVOTs have collectively contributed significantly to our understanding of the cardiovascular outcomes related to GLP-1 receptor agonists
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
However, the evidence gap between these compounds cannot be overstated
doi: 10.1002/dmrr.3106
doi: 10.1111/bph.13720
Emerging Safety Concerns Recent research has identified new safety considerations beyond traditional gastrointestinal effects
